A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

Fracture Risk Scale An innovative tool for assessing & managing fracture risk in long-term care Did you know? WHY IS PREVENTING FRACTURES IN LONG-TERM CARE IMPORTANT? The fracture rate in […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

Cook with OC Cook with OC Osteoporosis Canada is providing strategies, new ideas and recipes to help you get the bone building nutrients needed for bone health. Nutrition is a […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

Peace Arch Hospital, BC Peace Arch Hospital, BC Establishment of A FLS Training and Mentorship Program for the Peace Arch Hospital in B.C. Establishment of A FLS Training and Mentorship […]

Latest News CIHR Institute of Aging’s Knowledge Mobilization December 5, 2023 The Canadian Institutes of Health Research (CIHR) Institute of Aging’s (IA) Knowledge Mobilization webpage has shared links on information […]